X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Middle East and Africa In-Vitro Diagnostics Companies

This report lists the top Middle East and Africa In-Vitro Diagnostics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Middle East and Africa In-Vitro Diagnostics industry.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Middle East and Africa In-Vitro Diagnostics Top Companies

  1. Abbott Laboratories

  2. Roche

  3. Beckton Dickinson

  4. Sysmex

  5. bioMérieux

*Disclaimer: Top companies sorted in no particular order

Middle East and Africa In-Vitro Diagnostics Market Major Players

Middle East and Africa In-Vitro Diagnostics Market Concentration

Middle East and Africa In-Vitro Diagnostics  Market Concentration

Middle East and Africa In-Vitro Diagnostics Company List

                            • Abbott Laboratories

                            • Danaher Corporation

                            • F. Hoffmann-La Roche AG

                            • Becton, Dickinson and Company

                            • BioMerieux SA

                            • Siemens Healthineers

                            • Thermo Fischer Scientific Inc.

                            • Qiagen N.V

                            • Seegene Inc.

                            • Sysmex Corporation


                        Specific to Middle East and Africa In-Vitro Diagnostics Market
                        Need More Details On Market Players And Competitors?
                        Download PDF

                        Middle East and Africa In-Vitro Diagnosis & Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)